July 2015 Issue of The Medicine Maker

The US Centers for Disease Control and Prevention has officially declared an “epidemic of prescription drug abuse”.

A new mathematical model aims to improve drugs for cancer, viruses and bacteria.

After 28 years of R&D at GSK, the world has its first malaria vaccine.

The first US biosimilar - Zarxio from Sandoz - has been cleared for market. But the judges say it wasn't an easy decision.

Engineered E. coli colonies could be trump cards in the war against drug resistance.

Porous shells - inspired by sea urchins - help defend biomacromolecules from the outside world.

Several companies are faced with recall woes thanks to insects, dodgy closures and broken tablets.

Are ancient texts hiding the answer to antibiotic resistance?

Manufacturing is getting smarter; only a cross-discipline approach will ensure the success of tomorrow’s processes.

How can we fight the global pandemic of falsified and substandard medicines?

Prescription drug abuse has already reached epidemic proportions in the US – and other countries look set to follow the dangerous trend.

Abusers are finding ways to circumvent current abuse-deterrent measures, leaving companies in need of new strategies.

The biopharma industry has a long way to go before it’s ready to embrace superior manufacturing models. Why?

Farid and her team have developed a range of software tools to help biopharma companies make decisions on the best manufacturing processes.

The true path to success as an entrepreneur is the ability to spot high impact problems – and to be fearless in the pursuit of great solutions.

Personalized medicine looks set to transform the biopharma landscape, and will demand significant changes in production methods.

Sitting Down With… Carsten Brockmeyer, CEO, Formycon, Germany.

The December issue will feature our inaugural Innovation Awards, recognising the most exciting new technologies of 2015.

Lawrence (Larry) Lesko is a bioanalytical veteran with many years of academic and FDA experience under his belt.

The techniques of laser diffraction and automated particle imaging support the fast, cost-effective development of nasal spray products, simultaneously providing the data required for regulatory compliance. This paper examines their application.

It is well established that the use of nanotechnology in medicine and more specifically drug delivery is spreading rapidly.

Dissecting a ligand into smaller fragments can provide a strategy for analyzing the role of key functional groups in a protein-ligand interaction.